These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3835497)

  • 1. Quantitative EEG and neuropsychological effects of piracetam and of the association piracetam-lecithin in healthy volunteers.
    Sannita WG; Balestra V; Rosadini G; Salama M; Timitilli C
    Neuropsychobiology; 1985; 14(4):203-9. PubMed ID: 3835497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Piracetam and vigilance. A study of EEG changes and clinical effects in gerontopsychiatric patients (author's transl)].
    Bente D; Glatthaar G; Ulrich G; Lewinsky M
    Arzneimittelforschung; 1978; 28(9):1529-30. PubMed ID: 383104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of piracetam on EEG spectra of boys with learning disorders.
    Volavka J; Simeon J; Simeon S; Cho D; Reker D
    Psychopharmacology (Berl); 1981; 72(2):185-8. PubMed ID: 6782609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental electroencephalographic study of piracetam in cats.
    Nikolova M
    Methods Find Exp Clin Pharmacol; 1981; 3(6):367-75. PubMed ID: 7329161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative EEG and psychometric analyses in assessing CNS-activity of Ro 13-5057--a cerebral insufficiency improver.
    Saletu B; Grünberger J; Linzmayer L
    Methods Find Exp Clin Pharmacol; 1980 Oct; 2(5):269-85. PubMed ID: 6927816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-dose piracetam effects on global complexity measures of human spontaneous multichannel EEG.
    Kondakor I; Michel CM; Wackermann J; Koenig T; Tanaka H; Peuvot J; Lehmann D
    Int J Psychophysiol; 1999 Oct; 34(1):81-7. PubMed ID: 10555876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-blind, placebo-controlled, pharmacokinetic and -dynamic studies with 2 new formulations of piracetam (infusion and sirup) under hypoxia in man.
    Saletu B; Hitzenberger G; Grünberger J; Anderer P; Zyhlarz G; Linzmayer L; Rameis H
    Int J Clin Pharmacol Ther; 1995 May; 33(5):249-62. PubMed ID: 7655763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of scopolamine (0.25-0.75 mg i.m.) on the quantitative EEG and the neuropsychological status of healthy volunteers.
    Sannita WG; Maggi L; Rosadini G
    Neuropsychobiology; 1987; 17(4):199-205. PubMed ID: 3441275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The acute and chronic administrations of piracetam affect the movement-related brain macropotentials.
    Chiarenza GA; Ragaini C; Guareschi Cazzullo A
    Int J Psychophysiol; 1990 Apr; 8(3):223-34. PubMed ID: 2338403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Piracetam and brain excitability. An electrophysiological study in cats.
    Dimov S; Moyanova S; Nikolov R; Nikolova M
    Methods Find Exp Clin Pharmacol; 1984 Feb; 6(2):83-9. PubMed ID: 6717174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of piracetam on the central action of ethanol in mice and rabbits.
    Czarnecka E; Stanisławska E
    Pol J Pharmacol Pharm; 1983; 35(6):451-65. PubMed ID: 6677895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacodynamic bioequivalence of piracetam in hypoxic hypoxia].
    Schaffler K
    Arzneimittelforschung; 1986 May; 36(5):845-9. PubMed ID: 3730020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative EEG and behavioral effects in volunteers of a new benzodiazepine (SAS 643) in relation to drug plasma concentration.
    Sannita WG; Cabri M; Montano VF; Rosadini G
    Ther Drug Monit; 1981; 3(4):341-9. PubMed ID: 6121403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative neurophysiological study of the nootropic drugs piracetam and centrophenoxine].
    Krapivin SV; Voronina TA
    Farmakol Toksikol; 1987; 50(6):17-20. PubMed ID: 3125062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The significance of quantified EEG in Alzheimer's disease. Changes induced by piracetam].
    Pierlovisi-Lavaivre M; Michel B; Sebban C; Tesolin B; Chave B; Sambuc R; Melac M; Gastaut JL; Poitrenaud J; Millet Y
    Neurophysiol Clin; 1991 Dec; 21(5-6):411-23. PubMed ID: 1808500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topographic approaches in human quantitative pharmaco-electroencephalography.
    Sannita WG; Ottonello D; Perria B; Rosadini G; Timitilli C
    Neuropsychobiology; 1983; 9(1):66-72. PubMed ID: 6136937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Encephalotropic and psychotropic effects of intravenous buflomedil in the elderly: double-blind, placebo-controlled pharmaco-EEG and psychometric studies.
    Saletu B; Grünberger J; Linzmayer L; Stöhr H
    Int J Clin Pharmacol Res; 1984; 4(2):95-107. PubMed ID: 6469443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphatidylserine: quantitative EEG effects in healthy volunteers.
    Rosadini G; Sannita WG; Nobili F; Cenacchi T
    Neuropsychobiology; 1990-1991; 24(1):42-8. PubMed ID: 2132640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Characteristics of the pharmacological action of piracetam].
    Mashkovskiĭ MD; Roshchina LF; Polezhaeva AI
    Farmakol Toksikol; 1977; 40(6):676-83. PubMed ID: 598489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations of the fetal EEG under the influence of labour, hypoxia and analgetics.
    Klink F; von Klitzing L; Grosspietzsch R; Oberheuser F
    J Perinat Med; 1981; 9 Suppl 1():131-2. PubMed ID: 7229864
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.